HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) EVP Michael Schlosser sold 1,200 shares of HCA Healthcare stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total value of $593,580.00. Following the completion of the sale, the executive vice president directly owned 1,443 shares in the company, valued at $713,779.95. This trade represents a 45.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
HCA Healthcare Trading Down 2.6%
Shares of HCA Healthcare stock opened at $494.44 on Friday. The stock has a 50 day moving average of $443.66 and a 200 day moving average of $445.25. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The firm has a market cap of $103.28 billion, a PE ratio of 16.38, a PEG ratio of 1.65 and a beta of 1.11.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. The business had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.96 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 10.34%.
Institutional Investors Weigh In On HCA Healthcare
Hedge funds and other institutional investors have recently modified their holdings of the business. Condor Capital Management boosted its stake in HCA Healthcare by 1.8% in the third quarter. Condor Capital Management now owns 10,926 shares of the company’s stock valued at $4,663,000 after acquiring an additional 192 shares in the last quarter. Wellington Grp LLC increased its position in shares of HCA Healthcare by 51.4% during the third quarter. Wellington Grp LLC now owns 3,303 shares of the company’s stock worth $1,410,000 after purchasing an additional 1,122 shares in the last quarter. BCV Asset Management Inc. lifted its holdings in shares of HCA Healthcare by 2.6% during the 3rd quarter. BCV Asset Management Inc. now owns 74,598 shares of the company’s stock valued at $31,963,000 after purchasing an additional 1,904 shares during the last quarter. ProVise Management Group LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter worth $255,000. Finally, Money Concepts Capital Corp boosted its position in shares of HCA Healthcare by 6.7% in the 3rd quarter. Money Concepts Capital Corp now owns 719 shares of the company’s stock worth $307,000 after purchasing an additional 45 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare News Summary
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
- Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
- Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
- Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
- Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
- Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
- Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement
Wall Street Analysts Forecast Growth
Several research analysts recently commented on HCA shares. Oppenheimer dropped their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday, July 27th. Mizuho set a $495.00 price objective on HCA Healthcare in a research note on Wednesday, October 28th. Barclays lifted their target price on HCA Healthcare from $387.00 to $401.00 and gave the stock an “equal weight” rating in a report on Thursday, October 29th. Robert W. Baird boosted their target price on HCA Healthcare from $393.00 to $409.00 and gave the company a “neutral” rating in a research report on Wednesday, October 28th. Finally, TD Cowen increased their target price on shares of HCA Healthcare from $460.00 to $486.00 and gave the company a “buy” rating in a research note on Wednesday, October 28th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $480.13.
Get Our Latest Stock Analysis on HCA
HCA Healthcare Company Profile
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.
The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.
Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
